| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Depts of Child Health and 2 Clinical Biochemistry, The Queen's University of Belfast and 3 The Royal Belfast Hospital for Sick Children, Belfast, UK
CORRESPONDENCE: M.D. Shields, The Dept of Child Health, The Queen's University of Belfast, The Institute of Clinical Science, Grosvenor Road, Belfast, BT12 6BJ, UK. Fax: 44 2890236455. E-mail: E-mail: m.shields@qub.ac.uk
Keywords: airways inflammation, asthma, eosinophils
Received: September 6, 2001
Accepted October 8, 2001
This study was supported by the National Asthma Campaign, UK and the Research and Development Office for Northern Ireland.
 |
Abstract |
|---|
 TOP Abstract MethodsResultsDiscussionReferences |
|---|
Nonbronchoscopic bronchoalveolar lavage was performed on normal children (n=35) and children who had wheezed previously (n=35).
Eosinophils were raised in the lavage fluid of atopic children who had apparently outgrown asthma (median (interquartile range) 0.36 (0.05–0.74) compared to controls 0.10 (0–0.18), p=0.002). There was no relationship between length of remission and degree of airways eosinophilia.
Thus, there is persistent airways inflammation in some children with outgrown asthma and this may be a risk factor for future relapse.
It is well recognized that children with asthma often enter remission, commonly in the second decade of life, and seem to outgrow their asthma 1, 2. Studies have shown that 30–80% of previous asthmatics may relapse in later life 1–5. Eosinophilic airways inflammation plays an important role in asthma and the current thinking is that undertreatment of airways inflammation may lead to long-term structural changes such as airways remodelling and irreversible airflow obstruction 6. While studies have documented pulmonary function abnormalities and bronchial hyperresponsiveness in previous childhood asthmatics 2, 7–11, to the best of the authors' knowledge there are no reports of persistent airways inflammation in children who have outgrown asthma. This study examined direct measures of airways inflammation in children who had had wheezing episodes in the past.
|
Methods |
|---|
|
TOPAbstractMethodsResultsDiscussionReferences |
|---|
PW was defined as episodes of wheezing in the past, but no symptoms for at least 12 months and currently on no medication. After the administration of a detailed respiratory/atopy questionnaire 12, the PW group was subdivided into atopic asthma outgrown (AAO) and viral wheeze outgrown (VWO) on the basis of atopic status and clinical history. Atopy was defined as in previous publications 12, 13 as either a personal history of atopic disease, or two first-degree relatives with atopic disease or a raised total serum immunoglobulin-E (IgE). None of the control group were atopic. The Mann-Whitney U- and Kruskal-Wallis (with multiple comparisons adjustment) tests were used to compare BAL eosinophil percentages between subgroups. Spearman's correlations were performed to examine the relationship between length of remission and BAL eosinophil percentage.
|
Results |
|---|
|
TOPAbstractMethodsResultsDiscussionReferences |
|---|
. The PW group had significantly higher eosinophil percentages (median % (interquartile range): 0.3 (0–0.64)) when compared to the normal control group (0.1 (0–0.18), p=0.002). The median eosinophil percentage was higher in the AAO group compared with the normals (difference in median 0.27, 95% confidence interval 0.09–0.49, p=0.002, fig. 1). Three of the six children in the AAO group with elevated eosinophils had a raised IgE and a personal history of allergic disease at the time of examination. Of the other three, one child had atopic eczema and the two others had a strong family history of atopy. Nineteen children in the AAO group did not have raised eosinophils and five of these subjects had an elevated IgE level. Three of these five subjects had a personal history of allergic disease compared with six of the remaining 12. There were no differences between the groups for any other cell type in BAL. There was no correlation between duration of remission in the AAO group and degree of airway eosinophilia (r=0.12, p=0.6).
|
|
|
Discussion |
|---|
|
TOPAbstractMethodsResultsDiscussionReferences |
|---|
Nonatopic children who had wheezed previously, only in association with upper respiratory tract infections were classified as VWO. These children did not have raised BAL eosinophil percentages when compared with normal controls. This would be in keeping with the present understanding of viral wheeze being a condition usually limited to early childhood and carrying an excellent long-term prognosis 14, 15. A previous study from this research group has also shown that there is no evidence of eosinophilic inflammation in current viral wheezers 13, and the values for all other cell types in the VWO and AAO groups were similar to values published previously 12, 13.
The possibility that the raised BAL eosinophil percentages may be related to the length of remission was considered. However, as the results show, there was no relationship between these two variables, which suggests that these findings are not simply reflecting the gradual subsidence of airways inflammation, as remission increases in duration.
It is accepted that a number of children who have apparently "outgrown" their asthma will relapse in later life. Asthma disease severity, degree of airflow obstruction and bronchial hyperresponsiveness are thought to be potential predictors of the persistence of asthma symptoms or future relapse of asthma 3. It seems reasonable to also consider that persistent airways inflammation may be a risk factor that could predict those patients at risk of future relapse. Van den Toorn et al. 16 have shown that adolescents in asthma remission have elevated levels of exhaled nitric oxide (ENO), which corresponds to persistent bronchial hyperresponsiveness. ENO is thought to be a noninvasive marker of airways inflammation and further prospective studies are required to examine the possibility that ENO corresponds with persistent airways inflammation, and hence, may be a noninvasive predictor of future asthma relapse. This study was a case-control study, which carries its own limitations. In an ideal situation, a group of asthmatics would have been followed-up prospectively and had BAL performed at regular intervals, however, for ethical reasons this was not possible. Future work may address this issue by follow-up of children using induced sputum or possibly ENO measurements. The children in this study who had outgrown their asthma had a median age of 7.3 yrs, which is younger than the traditionally perceived age for outgrowing asthma, that of the early teenage years. This may reflect that the children in this study had mild asthma, which makes the presence of persisting inflammation in some of them more noteworthy.
In a previous study, the authors have shown that the upper limit of normal for BAL eosinophil percentage is 0.7% 12. The finding that eosinophils in BAL are elevated in some children (24% above normal range) who no longer wheeze, would suggest other components of inflammation need to be present for symptoms to persist. Recent studies have highlighted the potential contribution of neutrophils in asthmatic inflammation 17, 18. The present study however, does not demonstrate any difference in BAL neutrophil percentage in previous asthmatics compared with normal controls. In a previous study from this group, neutrophilic airways inflammation was only found in children with chronic nonspecific cough 19. Obase et al. 20 studied induced sputum from symptom-free young adults with a previous history of childhood asthma. They found elevated sputum eosinophils, eosinophil cationic protein and tumour necrosis factor-
in some of these subjects compared to normal controls, but normal levels of granulocyte-macrophage colony-stimulating factor (a cytokine involved in eosinophil activation) when compared to symptomatic asthmatics 20. Further study of this outgrown asthma group may help determine what has been "switched off" in the asthmatic inflammatory process.
In conclusion, the authors have shown that eosinophilic airways inflammation may persist in atopic children who have apparently outgrown asthma, and it is speculated that this may have implications for the risk of future relapse in these individuals.
|
References |
|---|
|
TOPAbstractMethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  M. W. Pijnenburg, E. M. Bakker, W. C. Hop, and J. C. De Jongste Titrating Steroids on Exhaled Nitric Oxide in Children with Asthma: A Randomized Controlled Trial Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 831 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Guerra Clinical remission of asthma: what lies beyond? Thorax, January 1, 2005; 60(1): 5 - 6. [Full Text] [PDF]
|
|
|
|
|
|
J M Vonk, D S Postma, H M Boezen, M H Grol, J P Schouten, G H Koeter, and J Gerritsen Childhood factors associated with asthma remission after 30 year follow up Thorax, November 1, 2004; 59(11): 925 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Maghni, C. Lemiere, H. Ghezzo, W. Yuquan, and J.-L. Malo Airway Inflammation after Cessation of Exposure to Agents Causing Occupational Asthma Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 367 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Adelsberg A management strategy that controls lower airway eosinophilic inflammation and symptoms reduced exacerbations in asthma Evid. Based Med., July 1, 2003; 8(4): 113 - 113. [Full Text] [PDF]
|
|
|
|
|
|
L.-P. Boulet Asymptomatic Airway Hyperresponsiveness: A Curiosity or an Opportunity to Prevent Asthma? Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 371 - 378. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
